Stay updated on BOS for EoE Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the BOS for EoE Adolescents & Adults Clinical Trial page.

Latest updates to the BOS for EoE Adolescents & Adults Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA banner announces an NIH-wide transition from “Artificial Intelligence” to “Super Intelligence.” The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check25 days agoChange DetectedThe clinical trial record is no longer displayed; the page shows a 403 Forbidden message and a Home link instead.SummaryDifference18%

- Check32 days agoChange DetectedThe clinical trial record for the long-term budesonide oral suspension study in adolescents and adults with eosinophilic esophagitis is displayed, with study details, participant criteria, outcomes, record history, and related documents and publication.SummaryDifference72%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error page, replacing the previous study record content and showing a simple header with a Home link. This indicates restricted access to the NCT03245840 record.SummaryDifference18%

- Check53 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating an update to the study record’s presentation and metadata. This update likely reflects minor corrections or enhancements to how the study information is displayed.SummaryDifference0.0%

Stay in the know with updates to BOS for EoE Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS for EoE Adolescents & Adults Clinical Trial page.